ZEISS Presents Half-year Financial Figures
Despite weak trend in Semiconductor Manufacturing Technology, investment programs continue at fast pace
The ZEISS Group concluded the first half of the year (ended 31 March) with revenue totaling EUR 1.978 billion (first six months of 2011/12: EUR 2.040 billion). Earnings (EBIT) reached a level of EUR 109 million (first six months of 2011/12: EUR 236 million). "As expected, the first half of fiscal year 2012/13 was more difficult than the equivalent period last year," said Dr. Michael Kaschke, President and CEO of Carl Zeiss AG. "Revenue and earnings are characterized by the partly very different and challenging developments in our markets and by the recessionary trends in the global economy. However, our half-year figures are solid and at the level that we planned." Once again, the strong growth of Industrial Metrology and Medical Technology was able to cushion the downturn in the Semiconductor Manufacturing Technology business.
In the first six months of fiscal year 2012/13 ZEISS hired around 470 new recruits, predominantly in Asia and Germany. In addition, ZEISS increased its expenditure on its research and development activities by 6 percent to EUR 191 million (first six months of 2011/12: EUR 180 million). With investments in property, plant and equipment totaling EUR 107 million (first six months of 2011/12: EUR 108 million), ZEISS is continuing to drive the expansion and modernization of the Group.
The previous year's figures are calculated on a like-for-like basis.
More information at www.zeiss.com/press
Jörg Nitschke, Carl Zeiss, Corporate Communications
Phone +49(0) 7364 20-3242, Email: firstname.lastname@example.org
The Carl Zeiss Group is an international leader in the fields of optics and optoelectronics. In the markets for Industrial Solutions, Research Solutions, Medical Technology and Consumer Optics, Carl Zeiss has contributed to technological progress all over the world for more than 160 years.
The Carl Zeiss Group develops and produces planetariums, eyeglass lenses, camera and cine lenses and binoculars as well as solutions for biomedical research, medical technology and the semiconductor, automotive and mechanical engineering industries. Carl Zeiss is present in over 40 countries around the globe with about 40 production sites, over 50 sales and service locations and approximately 20 research and development centers. Carl Zeiss AG is fully owned by the Carl Zeiss Stiftung (Carl Zeiss Foundation). Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany.